Non-inferiority trial
Term · Oncology and biomedicine · MLC-T-ONC-005898
A study that tests whether a new treatment is not worse than an active treatment it is being compared to. Non-inferiority trials are sometimes done when a placebo (an inactive treatment) cannot be used. These trials may show that a new treatment (such as a drug) is not worse than the active treatment being compared, and it may be safer and easier to take or cause fewer side effects.
| Identifier | MLC-T-ONC-005898 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005898",
"term": "Non-inferiority trial",
"field": "Oncology and biomedicine",
"definition": "A study that tests whether a new treatment is not worse than an active treatment it is being compared to. Non-inferiority trials are sometimes done when a placebo (an inactive treatment) cannot be used. These trials may show that a new treatment (such as a drug) is not worse than the active treatment being compared, and it may be safer and easier to take or cause fewer side effects.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/non-inferiority-trial/"
}
Record 11,924 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.